Skip to content

Probiotic Beverage Trial for Healthy Aging in Indian Adults

A randomized, double-blind, placebo-controlled trial evaluating a probiotic beverage for aging-related biomarkers in Indian adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096030
Enrollment
120
Registered
2025-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Probiotic millet beverage: The study will observe and compare influence of the beverage on aging biomarkers. The intervention groups include: (1) Non-probiotic beverage (NPB, placebo c

Sponsors

CSIR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria include healthy adults aged 40-65 years with BMI 18.5-29.9 kg/m², no chronic diseases, and ability to provide informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria encompass diagnosed psychiatric/neurodegenerative disorders, recent antibiotic or probiotic use (within 30 days), pregnancy/lactation, and known allergies to study interventions (ICMR-DBT, 2011; Barzilai et al., 2016).

Design outcomes

Primary

MeasureTime frame
To find an effective gerobiotic, millet based dietary solution for healthy aging.Timepoint: week 0 & week 24

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactKaila Nova Henna Jemimah

CSIR- CFTRI

muthukumar@cftri.res.in9542079547

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026